Sequenom's Share Price Doubles in June as Caliper Continues to Sag | GenomeWeb

Sequenom's Share Price Doubles in June as Caliper Continues to Sag

Jul 03, 2008

NEW YORK (GenomeWeb News) – Sequenom’s stock was by far the biggest gainer — more than doubling its price — in June among the 36 companies that comprise the GenomeWeb Daily News Index.

In a tough month for the stock market, in general, Sequenom’s shares rose 107.5 percent. On the other end of the spectrum, shares of Caliper Life Sciences continued to decline, falling 27.6 percent for the month of June.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Threats of Synthetic Biology

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

Deletion Is Hard to Do

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

So Just How Many Are There?

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

This Week in Genome Research

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.